Turner B B, McEwen B S
Brain Res. 1980 May 5;189(1):169-82. doi: 10.1016/0006-8993(80)90015-3.
The recurrence every 24 h of glucocorticoid elevation led us to investigate the temporal relationship between glucocorticoid receptor occupation in brain cell nuclei and the availability of cytosol sites. Adrenalectomized rats were injected i.v. with [3H]corticosterone in doses ranging from 15 to 106 nmol/kg. Peak nuclear binding occurred 1-2 h after [3H]corticosterone injection and was preceded by a peak of cytosol receptor labeling at 15-30 min. Yet 1 h after 55 or 105 nmol/kg [3H]corticosterone, no depletion in the total in vitro binding capacity of the cytosol could be detected even though estimated depletion should have been approximately 30% had it occurred. Injection of 80 nmol/kg of corticosterone per rat plus 40 nmol/kg dexamethasone also failed to reduce total cytosol binding capacity, even though estimated depletion should have been approximately 40%. No change in binding affinity of cytosol sites was observed in the injected animals compared to uninjected controls. The in vivo nuclear binding capacity of hippocampus for [3H]corticosterone (fmol/hippocampus) is about 40% of the cytosol binding capacity measured in vitro. Moreover, no more than 40% of total cytosol sites are occupied in vivo as a result of [3H]corticosterone injections which occupy nuclear sites to 80% of estimated capacity. Yet, even with the larger in vitro cytosol binding capacity, a depletion approaching 40% of cytosol binding sites would have been seen, had it occurred as a result of nuclear translocation. The apparent lack of depletion of cytosol receptors is supported by experiments which showed that two injections of [3H]corticosterone 2 h apart fail to fatigue the nuclear uptake mechanism. The present results suggest (1) that in the hippocampus an excess of extranuclear glucocorticoid binding proteins exists, and (2) that the availability of functional cytosol receptors may be regulated to maintain a relatively constant cellular level.
糖皮质激素每24小时升高一次,这促使我们研究脑细胞核中糖皮质激素受体占据情况与胞浆位点可用性之间的时间关系。对肾上腺切除的大鼠静脉注射剂量范围为15至106 nmol/kg的[3H]皮质酮。[3H]皮质酮注射后1 - 2小时出现核结合峰值,在此之前15 - 30分钟胞浆受体标记出现峰值。然而,在注射55或105 nmol/kg [3H]皮质酮1小时后,即使估计的消耗如果发生应该约为30%,也未检测到胞浆总体外结合能力的消耗。每只大鼠注射80 nmol/kg皮质酮加40 nmol/kg地塞米松也未能降低胞浆总结合能力,即使估计的消耗应该约为40%。与未注射的对照相比,注射动物的胞浆位点结合亲和力没有变化。海马体对[3H]皮质酮的体内核结合能力(fmol/海马体)约为体外测量的胞浆结合能力的40%。此外,由于[3H]皮质酮注射使核位点占据到估计能力的80%,体内胞浆位点被占据的比例不超过40%。然而,即使体外胞浆结合能力更大,如果是由于核转位导致胞浆结合位点消耗接近40%,也是可以看到的。实验表明,间隔2小时两次注射[3H]皮质酮不会使核摄取机制疲劳,这支持了胞浆受体明显没有消耗的观点。目前的结果表明:(1)在海马体中存在过量的核外糖皮质激素结合蛋白;(2)功能性胞浆受体的可用性可能受到调节以维持相对恒定的细胞水平。